gramneg
pathogeninduc
nosocomi
infect
resist
seriou
menac
global
public
health
qingfei
xiaoyan
wan
qf
tradit
chines
medicin
tcm
formula
use
clinic
china
treatment
upper
respiratori
tract
infect
acut
chronic
bronchiti
pulmonari
infect
studi
effect
qf
pseudomona
aeruginosainduc
acut
pneumonia
mice
evalu
mechan
four
typic
antiinflammatori
ingredi
qf
arctigenin
atg
cholic
acid
cla
chlorogen
acid
cga
sinap
acid
spa
regul
antiinflammatori
signal
pathway
relat
target
investig
use
molecular
biolog
molecular
dock
techniqu
result
show
pretreat
qf
significantli
inhibit
releas
cytokin
chemokin
rant
reduc
leukocyt
recruit
inflam
tissu
amelior
pulmonari
edema
necrosi
addit
atg
identifi
primari
antiinflammatori
agent
action
rasmapk
pathway
cla
cga
enhanc
action
atg
exhibit
synergist
inactiv
effect
possibl
via
rasmapk
signal
pathway
moreov
cla
specul
target
fgfr
mek
firstli
overal
qf
regul
rasmapk
pathway
inhibit
pathogen
bacteri
infect
effect
may
challeng
clarifi
tradit
chines
medicin
tcm
therapi
mechan
usual
unclear
mani
ingredi
herbal
formula
may
exert
effect
regul
multipl
pathway
target
recent
tcm
consid
highlight
target
interconnect
pathway
use
cure
complex
diseas
integr
tcm
network
pharmacolog
provid
innov
approach
tcm
theori
reductionist
holist
medicin
bridg
tradit
applic
modern
drug
discoveri
tcm
wide
use
clinic
treatment
infecti
diseas
thousand
year
china
base
differ
philosophi
western
medicin
base
antibiot
tcm
also
play
import
role
prevent
treatment
infect
sever
larg
respiratori
diseas
outbreak
sever
acut
respiratori
syndrom
sar
acquir
pneumonia
although
precis
mechan
action
remain
unclear
perspect
modern
medicin
therapeut
regimen
combin
chines
western
medicin
gain
accept
reduc
resist
toxic
qingfei
xiaoyan
wan
qf
pill
deriv
classic
tcm
prescript
max
shigan
decoct
consist
eight
common
chines
herbal
medicin
herba
ephedra
gypsum
fibrosum
pheretima
fructu
arctii
semen
lepidii
bovi
calculu
semen
armeniaca
amarum
cornu
saiga
tatarica
qf
approv
china
food
drug
administr
use
clinic
treatment
upper
respiratori
tract
infect
acut
bronchiti
acut
exacerb
chronic
bronchiti
pulmonari
infect
excel
clinic
effect
previou
studi
qf
allevi
asthma
antiinflammatori
activ
four
type
inhibitor
includ
arctigenin
atg
deriv
cholic
acid
cla
deriv
chlorogen
acid
cga
sinap
acid
spa
screen
studi
antiinflammatori
compound
quantifi
use
ultraperform
liquid
chromatographi
uplc
system
effect
qf
pseudomona
aeruginosainduc
lung
infect
mice
investig
possibl
synerget
antiinflammatori
mechan
suppress
bacteri
pneumonia
mutual
regul
ra
mapk
pathway
identifi
atg
spa
cla
cga
arctiin
deoxychol
acid
glycochol
acid
deoxyglycochol
acid
obtain
yifang
tianjin
china
enzymelink
immunosorb
assay
elisa
assay
kit
rat
rant
well
human
intracellular
protein
total
jnk
erk
obtain
pierceendogen
co
rockford
illinoi
usa
human
purchas
peprotech
rocki
hill
nj
usa
dexamethason
dex
levofloxacin
lev
purchas
sigma
chemic
co
st
loui
mo
usa
reagent
cell
cultur
obtain
gibco
brl
life
technolog
rockvil
md
usa
luciferas
report
plasmid
renilla
luciferas
report
vector
plasmid
prltk
obtain
promega
co
fitchburg
wi
usa
lipofectamin
transfect
reagent
obtain
invitrogen
carlsbad
ca
usa
antibodi
obtain
santa
cruz
biotechnolog
san
diego
ca
usa
p
aeruginosa
pak
strain
clinic
isol
sputum
patient
suffer
bronchiectasi
provid
professor
mingqiang
qiao
colleg
life
scienc
nankai
univers
china
reagent
use
studi
analyt
grade
commerci
qf
batch
donat
tianjin
zhongxin
pharmaceut
group
co
ltd
darentang
pharmaceut
factori
tianjin
china
qf
pill
powder
suspend
distil
water
qf
suspens
lev
directli
dilut
physiolog
salin
administr
mice
qf
suspens
dex
atg
cla
cga
spa
dissolv
dimethylsulfoxid
dmso
vitro
experi
final
concentr
dmso
ad
cell
less
kunm
mice
male
g
purchas
experiment
anim
center
nation
institut
control
pharmaceut
biolog
product
beij
china
anim
treatment
mainten
perform
accord
principl
laboratori
anim
care
nih
public
revis
anim
ethic
committe
nankai
univers
approv
experiment
protocol
anim
hous
separ
cage
food
water
freeli
avail
standard
laboratori
condit
h
h
dark
cycl
sixti
mice
randomli
allot
six
group
includ
uninfect
control
group
con
five
p
aeruginosa
infect
group
follow
model
group
mod
posit
control
group
lev
lowmediumhigh
dose
qf
group
qflqfmqfh
lev
mgkgd
three
dose
qf
gkgd
administ
oral
mice
one
week
p
aeruginosa
challeng
acut
lung
inflamm
challeng
perform
previous
describ
p
aeruginosa
pak
strain
use
experi
grown
luriabertani
lb
medium
necessari
pak
strain
cultur
duplic
lb
medium
overnight
wash
twice
phosphatebuff
salin
pb
resuspend
dilut
final
concentr
colonyform
unitsml
one
week
drug
administr
mice
except
control
group
challeng
ml
intratrach
pak
suspens
approxim
colonyform
unitslung
anesthet
mgkg
sodium
pentobarbit
ip
control
group
administ
volum
pb
via
rout
twentyfour
hour
p
aeruginosa
challeng
mice
anesthet
sodium
pentobarbit
mgkg
ip
blood
sampl
collect
retroorbit
caviti
serum
separ
supernat
collect
store
subsequ
test
lung
collect
place
formalin
least
week
organ
embed
paraffin
section
stain
hematoxylin
eosin
true
color
photograph
imag
slice
taken
use
light
microscop
olympu
japan
cell
cultur
transfect
assay
cell
line
deriv
human
bronchial
epitheli
cell
obtain
american
type
cultur
collect
rockvil
md
usa
cultur
medium
supplement
fetal
bovin
serum
penicillinstreptomycin
co
humidifi
incub
stimul
drug
supernat
collect
detect
cytokin
chemokin
simultan
cell
cotransfect
plate
luciferas
report
plasmid
renilla
luciferas
report
vector
plasmid
prltk
ng
per
well
respect
transfect
perform
h
use
lipofectamin
accord
manufactur
instruct
cell
pretreat
drug
stimul
human
ngml
h
stimul
cell
wash
lyse
assay
luciferas
activ
use
promegadualluciferas
report
assay
system
accord
manufactur
instruct
previous
report
cytokin
chemokin
rant
intracellular
protein
total
jnk
erk
supernat
plasma
homogen
lung
cell
cell
lysat
measur
use
commerci
elisa
kit
accord
manufactur
instruct
absorb
sampl
measur
nm
use
biorad
model
micropl
reader
cytokin
chemokin
intracellular
protein
level
determin
standard
curv
express
picogram
per
millilit
cell
wash
icecold
pb
lyse
use
lysi
buffer
sd
glycerol
mmoll
trishcl
buffer
ph
min
total
protein
cell
lysat
transfer
nitrocellulos
membran
follow
separ
sdspage
membran
block
skim
milk
solut
overnight
incub
polyclon
antibodi
h
wash
twice
tween
salin
ttb
blot
subsequ
incub
secondari
horseradish
peroxidaseconjug
rabbit
antibodi
h
room
temperatur
wash
extens
ttb
detect
perform
use
enhanc
chemiluminesc
kit
amersham
bioscienc
uppsala
sweden
describ
manufactur
follow
autoradiographi
quantit
analysi
antiinflammatori
compound
perform
previous
describ
slight
modif
water
acquiti
uplc
system
water
co
milford
equip
photodiod
array
detector
water
qtof
premier
electrospray
ioniz
esi
system
water
ms
technolog
manchest
uk
use
system
control
use
masslynx
softwar
water
co
acquiti
beh
column
mm
mm
water
co
use
separ
product
elut
gradient
vv
aqueou
formic
acid
mobil
phase
acetonitril
mobil
phase
b
mobil
phase
gradient
follow
b
min
b
min
b
min
b
min
b
min
b
min
flow
maintain
b
min
flow
rate
set
mlmin
column
temperatur
experiment
condit
qtofm
previous
report
stimul
drug
atg
cla
cga
spa
total
rna
extract
cell
trizol
invitrogen
ca
usa
accord
manufactur
instruct
cdna
synthes
use
highcapac
cdna
revers
transcript
kit
appli
biosystem
ca
usa
pcr
amplif
perform
analyz
triplic
use
gotaqqpcr
master
mix
promega
emiss
intens
bryt
green
detect
icycl
detect
system
biorad
hercul
ca
usa
express
level
gene
normal
intern
refer
gene
pcr
primer
rasmapk
jnk
erk
ra
pkc
pathway
fak
design
shown
tabl
antiinflammatori
candid
compound
select
structur
save
format
file
place
pharmmapp
databas
http
tar
get
predict
annot
pathway
analysi
perform
use
kyoto
encyclopedia
gene
genom
kegg
http
wwwgenomejpkegg
evalu
select
target
seri
candid
molecul
optim
use
sybyl
dock
target
crystal
structur
potenti
target
protein
obtain
protein
data
bank
id
http
wwwrcsborgpdb
stage
target
structur
preprocess
prepar
delet
water
molecul
hydrogen
atom
ad
next
grid
box
gener
dock
pdbqt
file
target
ligand
prepar
use
autodocktool
center
grid
place
center
mass
ligand
genet
algorithm
ga
use
simul
ligandreceptor
bind
number
ga
run
step
size
paramet
quaternion
torsion
set
compound
independ
run
perform
default
valu
use
paramet
data
express
deviat
sd
least
independ
experi
oneway
anova
student
ttest
use
statist
analysi
differ
consid
statist
signific
p
valu
less
evalu
effect
qf
acut
lung
inflamm
crosssect
lung
tissu
stain
shown
fig
pak
strain
infect
caus
capillari
congest
obstruct
small
airway
lymphocyt
infiltr
widen
alveolar
septa
compar
structur
integr
lung
tissu
control
group
pretreat
medium
highdos
qf
significantli
reduc
histolog
injuri
less
obstruct
small
airway
recruit
inflammatori
infiltr
respect
howev
histolog
damag
improv
lowdos
qf
evid
indic
medium
highdos
qf
amelior
p
aeruginosainduc
lung
infect
mice
proinflammatori
factor
activ
express
mani
cytokin
chemotact
factor
induc
sever
pulmonari
tissu
injuri
repres
cytokin
stimul
mucou
secret
promot
differenti
b
cell
cytotox
cell
mast
cell
induc
immun
cell
infiltr
rant
caus
mononuclear
leukocyt
eosinophil
granulocyt
particip
inflamm
p
aeruginosa
challeng
level
cytokin
chemokin
plasma
lung
homogen
measur
elisa
rant
significantli
increas
plasma
lung
tissu
p
aeruginosa
infect
shown
fig
pretreat
low
dose
qf
prevent
releas
rant
howev
treatment
medium
high
dose
qf
decreas
product
cytokin
differ
degre
respect
high
dose
qf
decreas
releas
rant
result
consist
histolog
chang
note
effect
qf
product
cytokin
also
studi
bronchial
epitheli
cell
vitro
pretreat
h
differ
dose
qf
qfl
mgml
qfm
mgml
qfh
mgml
perform
follow
ngml
stimul
h
posit
control
dex
medium
highdos
qf
significantli
suppress
express
fig
b
activ
compar
model
group
fig
howev
low
dose
qf
inhibitori
effect
verifi
effect
qfmediat
inhibit
western
blot
use
determin
whether
qf
inhibit
stimul
degrad
shown
fig
degrad
induc
suppress
qf
dosedepend
manner
result
demonstr
antiinflammatori
effect
qf
cellular
level
clarifi
content
antiinflammatori
ingredi
uplc
qtofm
use
identifi
amount
arctiin
spa
cga
cla
deriv
qf
fig
compar
cga
mgml
spa
mgml
amount
mgml
total
cla
deriv
mgml
includ
cla
mgml
deoxychol
acid
mgml
glycochol
acid
mgml
deoxyglycochol
acid
mgml
higher
qf
atg
primari
metabolit
oral
administr
arctiin
therefor
atg
cla
predict
play
major
role
antiinflammatori
process
compound
deriv
fructu
arctii
bovi
calculu
respect
investig
possibl
antiinflammatori
mechan
express
critic
gene
rasmapk
pathway
prove
effect
qfh
group
data
shown
determin
use
quantit
rtpcr
shown
fig
mrna
express
jnk
erk
fak
ra
pkc
upregul
greatli
ngml
stimul
h
model
group
compar
model
tabl
primer
probe
realtim
rtpcr
forward
activ
lowmolecularweight
gtpgdp
bind
gtpase
ra
regul
express
elucid
synergist
effect
combin
treatment
four
ingredi
detect
downstream
signal
transduct
fig
treatment
atg
cla
cga
spa
decreas
depend
transcript
atg
combin
cla
cga
spa
togeth
inhibit
greater
one
drug
result
indic
atg
import
inhibitor
pathway
mapk
three
famili
member
jnk
erk
inhibitor
decreas
activ
rasmapk
pathway
effect
singl
combin
treatment
differ
inhibitor
jnk
erk
intracellular
protein
level
ngml
stimul
cell
valid
elisa
shown
fig
treatment
atg
alon
significantli
suppress
level
jnk
erk
cga
suppress
express
jnk
cla
reduc
erk
spa
downregul
level
pair
applic
synergist
effect
atg
combin
cla
suppress
erk
level
wherea
atg
combin
cga
spa
primarili
affect
jnk
level
explor
potenti
protein
target
pharmacophor
match
platform
pharmmapp
server
util
target
dock
rasmapk
pathway
molecular
dock
valid
perform
autodock
provid
detail
inform
represent
ligand
regul
target
includ
atg
kcalmol
jnk
kcalmol
cla
fgfr
kcalmol
mek
kcalmol
cga
ra
kcalmol
hspa
kcalmol
rac
kcalmol
show
higher
score
rasmapk
pathway
identifi
potenti
target
howev
spa
kcalmol
fgfr
kcalmol
ra
kcal
mol
rac
kcalmol
lower
bind
energi
omit
analysi
detail
interact
inform
key
target
relat
compound
shown
fig
qingfei
xiaoyan
wan
tradit
chines
medicin
formula
amelior
pseudomona
aeruginosainduc
acut
base
kegg
analysi
result
key
antiinflammatori
network
qf
rasmapk
pathway
summar
fig
p
aeruginosainduc
pneumonia
complex
process
first
larg
number
thalli
aggreg
air
way
util
flagellum
fimbria
polysaccharid
membran
surfac
adher
respiratori
epithelia
immun
respons
host
activ
via
invas
type
iii
secretori
protein
quorumsens
system
pyocyanin
lp
virul
factor
consequ
cytokin
chemotact
factor
inflammatori
mediat
produc
host
cell
recruit
activ
macrophag
neutrophil
granulocyt
cell
result
sever
lung
injuri
mortal
studi
establish
mous
acut
pneumonia
model
p
aeruginosa
protect
effect
qf
estim
evalu
express
inflammatori
mediat
histopatholog
condit
result
indic
pretreat
qf
significantli
inhibit
releas
cytokin
chemokin
rant
reduc
leukocyt
recruit
inflam
tissu
amelior
pulmonari
edema
necrosi
promot
surviv
mice
rasmapk
two
import
pathway
cell
membran
receptor
signal
transduct
involv
inflammatori
immun
respons
lp
activ
pkc
initi
proinflammatori
signal
fak
ra
fak
protein
tyrosin
kinas
activ
mapk
regul
express
cytokin
immun
inflammatori
respons
furthermor
ra
gtpase
activ
erk
regul
gener
inflammatori
factor
contrast
bind
membran
receptor
activ
jak
cytokin
growth
factor
activ
mapk
regul
prolifer
differenti
cell
express
proinflammatori
factor
proinflammatori
factor
basic
factor
inflammatori
respons
also
act
gramneg
bacteria
posit
feedback
pathway
synergist
enhanc
infect
studi
cultur
cell
induc
select
inflamm
model
assess
anti
inflammatori
effect
qf
vitro
four
candid
compound
qf
select
determin
synergist
antiinflammatori
mechan
atg
repres
dibenzyl
butyrolacton
lignan
antiinflammatori
antivir
antitumor
ca
antagonist
activ
antiinflammatori
mechan
includ
suppress
overproduct
inhibit
jakstat
signal
pathway
lpsstimul
macrophag
inhibit
akt
phosphoryl
amelior
inflamm
inhibit
pathway
regul
activ
map
kinas
lead
inactiv
product
studi
atg
predict
target
downregul
phosphoryl
akt
pkc
affect
express
downstream
gene
map
kinas
cga
significantli
inhibit
express
ino
attenu
inflammationrel
marker
abolish
phosphoryl
akt
erk
regul
receptor
activ
ligand
induc
nuclear
factor
activ
cell
express
addit
effect
cga
lpsinduc
inflamm
may
due
abil
attenu
signal
pathway
studi
cga
suggest
bind
ra
protein
combin
atg
affect
erk
pathway
result
consist
previou
report
addit
mechan
antiinflammatori
effect
cla
spa
suppress
express
via
shown
previou
studi
studi
cla
simultan
target
upstream
protein
fgfr
downstream
protein
mek
rasmapk
pathway
specul
firstli
combin
atg
effect
also
occur
erk
subpathway
spa
smaller
molecular
structur
bind
activ
also
weaker
furthermor
low
content
spa
play
major
role
overal
antiinflammatori
effect
summari
network
mechan
sever
ingredi
identifi
qf
mutual
suppress
demonstr
regul
primari
intracellular
immun
respons
amelior
acut
pneumonia
induc
p
aeruginosa
atg
princip
ingredi
respons
antiinflammatori
effect
rasmapk
pathway
ingredi
cla
cga
enhanc
figur
effect
antiinflammatori
compound
qf
intracellular
protein
express
b
jnk
c
erk
cell
atg
cla
cga
spa
administ
use
alon
pair
combin
combin
drug
cell
lyse
drug
stimul
cell
lysat
analyz
elisa
jnk
erk
level
valu
shown
mean
independ
experi
vs
group
treat
absenc
drug
figur
scheme
propos
network
antiinflammatori
mechan
qf
rasmapk
pathway
action
atg
show
synergist
inactiv
effect
possibl
via
rasmapk
signal
pathway
